Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue SUPPL. 1, 2009, Pages 1-9

  Faustini, F ^a   Zoli, A ^a   Ferraccioli, G F ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

HLA B27; IBD; Idiopathic ankylosing spondylitis; IL 17; IL 23; Reumathoid arthritis; Sacroiliitis; Spondyloarthritis; Th1; Th2

Indexed keywords

BACTERIAL ANTIGEN; BETA7 INTEGRIN; CD163 ANTIGEN; HLA B27 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADAPTIVE IMMUNITY; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; BACTERIAL COLONIZATION; CD8+ T LYMPHOCYTE; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENTERITIS; GENE MUTATION; GENETIC LINKAGE; HOST SUSCEPTIBILITY; HUMAN; IMMUNOGENETICS; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; MUCOSAL IMMUNITY; NONHUMAN; SACROILIITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLOARTHROPATHY; SYSTEMATIC REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; ULCERATIVE COLITIS;

GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; MODELS, BIOLOGICAL; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLARTHROPATHIES;

EID: 65349186445     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. TORRES MI, RÌOS A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J Gastroenterol 2008; 14: 1972-1980.
2. VAN LIMBERGEN J, RUSSEL RK, NIMMO ER, HO GT, ARNOTT ID, WILSON DC, SATSANGI J. Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 338-355.
3. GREENSTEIN AJ, JANOWITZ HD, SOEHAR DB. Extra-intestinal complications of Crohn's disease and ulcerative colitis. Study of 700 patients. Medicine 1976; 55: 401.
4. KETHU SR. Extraintestinal manifestations of inflammatory bowel diseases. J Clin Gastroenterol 2006; 40: 467-475.
5. WITTIG BM, ZEITZ M. The gut as an organ of immunology. Int J Colorectal Dis 2003; 18: 181-187.
6. JUMP RL, LEVINE AD. Mechanisms of natural tolerance in the intestine: Implications for inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 462-478.
7. PODOLSKY DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429.
8. PODOLSKI DK, FIOCCHI C. Cytokines, chemokines, growth factors, eicosanoids, and other bioactive molecules in inflammatory bowel disease. In: Kirsner JB, editor. Inflammatory Bowel Disease. 5th ed. Philadelphia:PWB Saunders, 2000: pp. 191-207.
9. XAVIER RJ, PODOLSKI DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434.
10. BROWN SJ, MAYER L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007; 102: 2058-2069.
11. SCHREIBER S, HEINIG T, THIELE HG, READLER A. Immunoregulatory role of Interleukin-10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 1434-1444.
12. YEN D, CHEUNG J, SCHREERENS H, POULET F, MCCLANAHAN T, MCKENZIE B, KLEINSCHEK MA, OWYANG A, MATTSON J, BLUMENSCHEIN W, MURPHY E, SATHE M, CUA DJ, KASTELEIN RA, RENNICK D. IL-23 is essential for T-cell mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116: 1310-1316.
13. HUE S, AHERN P, BUONOCORE S, KULLBERG MC, CUA DJ, MCKENZIE BS, POWRIE F, MALOY KJ. Interleukin-23 drives innate and T-cell mediated intestinal inflammation. J Exp Med 2006; 203: 2473-2483.
14. FUJINO S, ANDOH A, BAMBA S, OGAWA A HATA K, ARAKI Y, BAMBA T, FUJIYAMA Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70.
15. DUERR RH, TAYLOR KD, BRANT SR, RIOUX JD, SILVERBERG MS, DALY MJ, STEINHART AH, ABRAHAM C, REGUEIRO M, GRIFFITHS A, DASSOPUOLOS T, BITTON A, YANG H, TARGAN S, DATTA LW, KISTNER EO, SCHUMM LP, LEE AT, GREGERSEN PK, BARMADA MM, ROTTER JI, NICOLAE DL, CHO JH. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463.
16. WRIGHT V, WATKINSON G. Articular complications of ulcerative colitis. Am J Proctol 1966; 17: 107-115.
17. DE VLAM K, MIELANTS H, CUVELIER C, DE KAYSER F, VEYS EM, DE VOS M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 2000; 27: 2860-2865.
18. DEKKER-SAEYS BJ, MEUWISSEN SG, VAN DEN BERG-LOONEN EM, DE HAAS WH, MEUERS KA, TYTGAT GN. Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. Ann Rheum Dis 1978; 37: 36-41; 17: 107-115.
19. RUSSELL AS, PERCY JS, SCHLAUT JS, SARTOR VE, GOODHART JM, SHERBANIUK RW, KIDD EG. Transplantation antigens in patients with Crohn's disease: The linkage of associated ankylosing spondylitis with HLA-B27. Am J Dig Dis 1995; 20: 359-361.
20. ORCHARD TR, WORDSWORTH BP, JEWELL DP. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history. Gut 1998; 42: 387-391.
21. WORDSWORTH BP. Arthritis and inflammatory bowel disease. Curr Rheumatol Rep 2000; 2: 87.
22. LEIRISALO-REPO M, TURUNEN U, STENMAN S, HELENIUS P, SEPPÄLÄ K. High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum 1994; 37: 23-31.
23. MIELANTS H, VEYS EM, CUVELIER C, DE VOS M, GOEMAERE S, DE CLERCO L, SCHATTEMAN L, GYSELBRECHT L, ELEWAUT D. The evolution of spondyloarthropaties in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995; 22: 2273-2278.
24. ALONSO FARTO JC, ARIAS IA, LOPEZ LONGO FJ, GONZALEZ FERNANDEZ CM, MONTEAGUDO SAEZ I, ORTEGA VALLE A, BASCONES M, PERÉZ VÁZQUEZ JM, CARREÑO PEREZ L. Clinical significance of abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropaties. Eur J Nucl Med 2000; 27: 1768-1773.
25. BAETEN D, DEMETTER P, CUVELIER CA, KRUITHOF E, VAN DAMME N, DE VOS M, VEYS EM, DE KEYSER F. Macrophages expressing the scavenger receptor CD163: A link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol 2002; 196: 343-350.
26. PACHECO-TENA C, ALVARADO DE LA BARRERA C, LOPEZ-VIDAL Y, VÁZQUEZ-MELLADO J, RICHAUD-PATIN Y, AMIEVA RI, LLORENTE L, MARTÍNEZ A, ZUÑIGA J, CIFUENTES-ALVARADO M, BURGOS-VARGAS R. Bacterial DNA in Synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology (Oxford) 2001; 40: 920-927.
27. STHAL HD, HUBNER B, SEIDL B, LIEBERT UG, VAN DER HEUDEN IM, WILBRINK B, KRAAN MC, EMMRICH F, TAK PP. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis 2000; 59: 342-346.
28. SIEPER J, FENDLER C, LAITKO S, SÖRENSEN H, GRIPENBERG-LERCHE C, HIEPE F, ALTEN R, KIETEL W, GROH A, UKSILA J, EGGENS U, GRANFORS K, BRAUN J. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: A three-month, multicentre, double-blind, randomized, placebo-controlled study. Arthritis Rheum 1999; 42: 1386-1396.
29. BAETEN D, DEMETTER P, CUVELIER C, VAN DEN BOSCH F, KRUITHOF E, VAN DAMME N, VERBRUGGEN G, MIELANTS H, VEYS EM, DE KEYSER F. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: Influence of disease duration and activity. Ann Rheum Dis 2000; 59: 945-953.
30. LALOUX L, VOISIN MC, ALLAIN J, MARTIN N, KERBOULL L, CHEVALIER X, CLAUDEPIERRE P. Immunohistological study of the entheses in spondyloarthropathies: Comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 2001; 60: 316-321.
31. VAN DAMME N, DE VOS M, BAETEN D, DEMETTER P, MIELANTS H, VERBRUGGEN G, CUVELIER C, VEYS EM, DE KEYSER F. Flow citometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy. Ann Rheum Dis 2001; 60: 495-499.
32. CAÑETE JD, MARTÍNEZ SE, FARRÉS J, SANMARTÍ R, BLAY M, GÓMEZ A, SALVADOR G, MUÑOZ- GÓMEZ J. Differential Th1/Th2 cytokine patterns in chronic arthritis: Interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 2000; 59: 263-268.
33. BAETEN D, VAN DAMME N, VAN DEN BOSCH F, KRUITHOF E, DE VOS M, MIELANTS H, VEYS EM, DE KEYSER F. Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNF-α. Ann Rheum Dis 2001; 60: 750-755.
34. VAN DEN BOSCH F, KRUITHOF E, BAETEN D, HERSSENS A, DA KEYSER F, MIELANTS H, VEYS EM. Randomized double-bilnd comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active sponbdyloarthropathy. Arthritis Rheum 2002; 46: 755-765.
35. SALMI M, JALKANEN S. Human leucocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol 2001, 166: 4650-4657.
36. DEMETTER P, BAETEN D, DE KEYSER F, DE VOS M, VAN DAMME N, VERBRUGGEN G, VERMEULEN S, MAREEL M, ELEWAUT D, MIELANTS H, VEYS EM, CUVELIER C. Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E cadherin/catenin complex. Ann Rheum Dis 2000; 59: 211-216.
37. BAETEN D, DE KEYSER F, MIELANTS H, VEYS EM. Immune linkages between inflammatory bowel disease and spondyloarthropathies. Curr Opin Rheumatol 2002; 14: 342-347.
38. BOYLE LH, GOODALL JC, OPAT SS, GASTON JS. The recognition of HLA-B27 by human CD4+ T lymphocytes. J Immunol 2001; 167: 2619-2624.
39. DEMETTER P, DE VOS M, VAN HUYSSE JA, BAETEN D, FERDINANDE L, PEETERS H, MIELANTS H, VEYS EM, DE KEYSER F, CUVELIER C. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163. Ann Rheum Dis 2005; 64: 321-324.
40. MADSEN KL. Inflammatory bowel disease: Lessons from the IL-10 gene deficient mouse. Clin Invest Med 2001; 24: 250-257.
41. HUGOT JP, CHAMAILLARD M, ZOUALI H, LESAGE S, CÉZARD JP, BELAICHE J, ALMER S, TYSK C, O'MORAIN CA, GASSULL M, BINDER V, FINKEL Y, CORTOT A, MODIGLIANI R, LAURENT-PUIG P, GOWER-ROUSSEAU C, MACRY J, COLOMBEL JF, SAHBATOU M, THOMAS G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
42. OGURA Y, BONEN DK, INOHARA N, NICOLAE DL, CHEN FF, RAMOS R, BRITTON H, MORAN T, KARALIUSKAS R, DUERR RH, ACHKAR JP, BRANT SR, BAYLESS TM, KIRSCHNER BS, HANAUER SB, NUÑEZ G, CHO JH. A farmeshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
43. HAMPE J, CUTHBERT A, CROUCHER PJ, MIRZA MM, MASCHERETTI S, FISHER S, FRENZEL H, KING K, HASSELMEYER A, MACPHERSON AJ, BRIDGER S, VAN DEVENTER S, FORBES A, NIKOLAUS S, LENNARD-JONES JE, FOELSCH UR, KRAWCZAK M, LEWIS C, SCHREIBER S, MATHEW CG. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925-1928.
44. CUTHBERT AP, FISHER SA, MIRZA MM, KING K, HAMPE J, CROUCHER PJ, MASCHERETTI S, SANDERSON J, FORBES A, MANSFIELD J, SCHREIBER S, LEWIS CM, MATHEW CG. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122: 867-74.
45. AHMAD T, ARMUZZI A, BUNCE M, MULCAHY-HAWES K, MARSHALL SE, ORCHARD TR, CRAWSHAW J, LARGE O, DE SILVA A, COOK JT, BARNARDO M, CULLEN S, WELSH KI, JEWELL DP. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122: 854-866.
46. ABREU MT, TAYLOR KD, LIN YC, HANG T, GAIENNIE J, LANDERS CJ, VASILIAUSKAS EA, KAM LY, ROJANY M, PAPADAKIS KA, ROTTER JI, TARGAN SR, YANG H. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123: 679-688.
47. PEETERS H, VANDER CRUYSSEN B, LAUKENS P, COUCKE P, MARICHAL D, VAN DEN BERGHE M, CUVELIER C, REMAUT E, MIELANTS H, DE KEYSER F, DE VOS M. Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease. Ann Rheum Dis 2004; 63: 1131-1134.
48. VAN DER PAARDT M, CRUSIUS JB, DE KONING MH, MURILLO LS, VAN DE STADT RJ, DUKMANS BA, PENA AS, VAN DER HORST-BRUINSMA IE. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immunol 2003; 4: 77-78.
49. LAUKENS D, PEETERS H, MARICHAL D, VANDER CRUYSSEN B, MIELANTS H, ELEWAUT D, DEMETTER P, CUVELIER C, VAN DEN BERGHE M, ROTTIERS P, VEYS EM, REMALIT E, STEIDLER L, DE KEYSER F, DE VOS M. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease. Ann Rheum Dis 2005; 64: 930-935.
50. PEETERS H, VANDER CRUYSSEN B, MIELANTS H, DE VLAM K, VERMEIRE S, LOUIS E, RUTGEERTS P, BELAICHE J, DE VOS M. Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol 2008; 23: 132-137.
51. CORDELL HJ, CLAYTON DG. Genetic association studies. Lancet 2005; 366: 1121-1131.
52. SALANTI G, SANDERSON S, HIGGINS JP. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 2005; 7: 13-20.
53. RAHMAN P, INMAN RD, GLADMAN DD, REEVE JP, PEDDLE L, MAKSYMOWYCH WP. Association of Interleukin-23 Receptor variants with Ankylosing spondylitis. Arthritis Rheum 2008; 58: 1020-1025.
54. REIMUND JM, WITTERSHEIM C, DUMONT S, MULLER CD, BAUMANN R, POINDRON P, DUCLOS B. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996; 16: 144-150.
55. SAIKI T, MITSUYAMA K, TOYONAGA A, ISHIDA H, TANIKAWA K. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol 1998; 33: 616-622.
56. BRENTANO F, OSPELT C, STANCZYK J, GAY RE, GAY S, KYBURZ D. Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: Differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis. Ann Rheum Dis 2009; 68: 143-150.